ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,414.99
-0.22%
Dow Jones
39,451.81
-0.15%
Gold vs US Dollar
2,335.785
-1.04%
Brent Oil
82.925
0.66%
Bitcoin
62,822.33
2.24%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vaxart Inc (VXRT)

  7. Vaxart Inc (VXRT) News

Vaxart (VXRT)

Vaxart Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VXRT
DateTimeSourceHeadlineSymbolCompany
13/05/202412:10IH Market NewsU.S. Futures Climb Amid High Expectations for Inflation Data; Global Markets Show Mixed ReactionsNASDAQ:VXRTVaxart Inc
07/05/202413:00GlobeNewswire Inc.Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13NASDAQ:VXRTVaxart Inc
30/04/202413:00GlobeNewswire Inc.Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
27/03/202412:00GlobeNewswire Inc.Vaxart to Present at World Vaccine Congress Washington 2024 on April 3NASDAQ:VXRTVaxart Inc
20/03/202412:00GlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VXRTVaxart Inc
14/03/202420:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Full Year 2023 Financial ResultsNASDAQ:VXRTVaxart Inc
14/03/202411:41IH Market NewsU.S. Stock Futures Rise Ahead Of PPI and Retail Sales; Oil Prices ClimbNASDAQ:VXRTVaxart Inc
07/03/202413:00GlobeNewswire Inc.Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14NASDAQ:VXRTVaxart Inc
06/03/202414:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
06/03/202413:00GlobeNewswire Inc.Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and DirectorNASDAQ:VXRTVaxart Inc
29/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
15/02/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
13/02/202422:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VXRTVaxart Inc
05/02/202413:00GlobeNewswire Inc.Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 ChallengeNASDAQ:VXRTVaxart Inc
02/02/202421:49Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VXRTVaxart Inc
19/01/202422:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
19/01/202421:30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VXRTVaxart Inc
19/01/202413:30GlobeNewswire Inc.Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
16/01/202422:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
16/01/202414:25GlobeNewswire Inc.Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital ManagementNASDAQ:VXRTVaxart Inc
16/01/202414:22GlobeNewswire Inc.Vaxart, Inc. Announces Management ChangeNASDAQ:VXRTVaxart Inc
16/01/202414:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
21/12/202313:00GlobeNewswire Inc.Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
02/11/202320:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
02/11/202320:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
02/11/202320:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:VXRTVaxart Inc
02/11/202312:00GlobeNewswire Inc.Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
26/10/202313:00GlobeNewswire Inc.Vaxart to Host Third Quarter 2023 Business Update and Financial Results Conference Call on November 2NASDAQ:VXRTVaxart Inc
23/10/202322:09Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VXRTVaxart Inc
23/10/202322:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
 Showing the most relevant articles for your search:NASDAQ:VXRT

Your Recent History

LSE
EEE
Empire Metals
LSE
SYME
Supply@me Capital
LSE
PET
Petrel Resources
LSE
BIRD
Blackbird
LSE
TERN
Tern
LSE
VAST
Vast Resources
LSE
RR.
Rolls-royce
LSE
KEFI
Kefi Gold And Copper
LSE
SFOR
S4 Capital
LSE
PANR
Pantheon Resources
LSE
GOLD
LSE
GKP
Gulf Keystone Petroleum
LSE
GILD
Guild Esports
LSE
VRS
Versarien
LSE
BOO
Boohoo
LSE
GFM
Griffin Mining
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved